America gets another Alzheimer's drug in its arsenal: FDA approves Eli Lilly's treatment that slows symptoms down

---

America gets another Alzheimer's drug in its arsenal: FDA approves Eli Lilly's treatment that slows symptoms down

---

The US FDA has approved donanemab, a treatment for Alzheimer's disease that is designed to slow the progression of early signs of the dementia. Made by Indianapolis-based Eli Lilly, donanemab is a monoclonal antibody treatment that helps the body remove the hallmark plaque that builds up in the brain and causes dementia. Clinical trials have shown the treatment slowed cognitive decline in patients by up to 35 percent. Now approved, Eli Lilly said it will be sold under the name Kisunla and will be administered by once-monthly IV infusions.
More >> https://ift.tt/M2aS897 Full Article on Source: #USMNT #Berhalter #CopaAmerica #Uruguay #WWERaw #Panama #SCOTUS
#us #uk #world #fashion #showbiz #celebrity #lifestyle #top #news